Salarius Pharmaceuticals, Inc. (SLRX) IPO - S-1 Filing, Stock & Insider Activity
Salarius Pharmaceuticals, Inc. IPO - Status & S-1 Filing
- Ticker: SLRX
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2026-06-15
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- SEC CIK: 0001615219 · View the S-1 on SEC EDGAR →
Salarius Pharmaceuticals, Inc. is pre-IPO, so no insider Form 4 transactions have been filed yet. Once insiders begin reporting trades after the offering, they will appear on this page automatically.
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Salarius Pharmaceuticals, Inc. (SLRX) - no SEC Form 4 insider filings recorded in the last 90 days. 3 Form 8-K material event filings were reported by SLRX in the last 90 days. InsiderAlpha tracks every SLRX SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Salarius Pharmaceuticals, Inc. (SLRX)
Salarius Pharmaceuticals, Inc. trades under the ticker SLRX. InsiderAlpha tracks 2 primary SEC Form 4 filings from 2 reporting insiders for SLRX since 2025, sourced directly from SEC EDGAR.
| SEC CIK | 0001615219 |
|---|
90-Day SEC Filing Activity
| Form 8-K filings (90d) | 3 |
|---|---|
| Latest Form 4 filing | 2025-11-24 |
Recent SLRX Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Arnold C. Hanish | Director | P - Open-market purchase | 5.0K | $0.75 | $4K | SEC | |
| Mark J. Rosenblum | Exec VP Finance, CFO | P - Open-market purchase | 20.0K | $0.80 | $16K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Salarius Pharmaceuticals, Inc. (SLRX). Updated in real time as new filings are submitted to the SEC.
Recent SLRX Form 8-K Material Events
- - Item 5.07 [SEC]
- - Item 1.01, 3.02, 7.01, 9.01 [SEC]
- - Item 5.08, 8.01 [SEC]
- - Item 8.01, 9.01 · Regulatory · negative [SEC]
Salarius Pharmaceuticals (now trading as Decoy Therapeutics) received a Nasdaq delisting notice for failing to maintain the $1.00 minimum bid price requirement. The company implemented a reverse stock split on March 6, 2026, and was granted until March 20, 2026, to regain complia - - Item 3.03, 5.03, 8.01, 9.01 · Restructuring · negative [SEC]
Decoy Therapeutics (formerly Salarius Pharmaceuticals) announced a 1-for-12 reverse stock split, effective March 6, 2026, to comply with Nasdaq Capital Market's continued listing requirements. The reverse split was approved by shareholders on February 24, 2026, and the Board auth
Recent Insider Filings
- - Arnold C. Hanish (Director)
- - Mark J. Rosenblum (Exec VP Finance, CFO)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in SLRX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
SLRX Insider Trading - FAQ
- What is the latest insider trade for SLRX?
- Salarius Pharmaceuticals, Inc. (SLRX) had 0 insider filings in the last 90 days, with the most recent on 2025-11-24. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying SLRX stock?
- 0 insider purchases of SLRX were filed in the last 90 days.
- How many insiders are selling SLRX stock?
- 0 insider sales of SLRX were filed in the last 90 days.
- Where can I see SLRX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks SLRX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $SMEGF Siemens Energy AG/ADR
- $SMX SMX (Security Matters) Public Ltd Co
- $SNAL Snail, Inc.
- $SNOA Sonoma Pharmaceuticals, Inc.
- $SNSC SunScout Holding Ltd
- $SOBR SOBR Safe, Inc.
- $SOEZ Franklin Solana Trust
- $SOPA SOCIETY PASS INCORPORATED.
- $SOUD Hacker Interstellar Inc.
- $SPCX SPACE EXPLORATION TECHNOLOGIES CORP
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live SLRX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.